Supplementary Tables.

Supplementary Table 1. The characteristics of included 13 patients undergoing nephrectomy due to renal cancers.Supplementary Table 2. Primer sequences for plasmid construction to overexpress NEAT1 and EGR1Supplementary Table 3. ShRNA sequences designed for NEAT1 and BMP2Supplementary Table 4. Sequences of Mimic and inhibitor for miRNAsSupplementary Table 5. Primer sequences for qRT-PCRSupplementary Table 6. The details of primary antibodies used in Western Blotting (WB)Supplementary Table 7. Primer sequences for CHIP-qPCRSupplementary Table 8. The transcription factors (TFs) binding to the promoter of BMP2 predicted by FIMO software, JASPAR and HOCOMOCO datasets, and RNA-Protein Interaction Prediction (RPISeq; http://pridb.gdcb.iastate.edu/RPISeq/#) was used to predict whether these TFs bind to NEAT1.Supplementary Table 9. The predicted sites of EGR1 binding to the promoter of BMP2.